thisdrug what a medicine's name tells you

WHO naming stem · anywhere in the name · 112 listed names

gli

This page was written with AI.

antihyperglycaemics

WHO's definition, quoted as written in the 2024 stem book

20 of 112 names appear in these lists: 18 in the US list (FDA Drugs@FDA) and 16 in the EU central list (EMA); 16 have national brands in at least one EU/EEA country.

Names only. This page is about gli as a part of a name. It has nothing on uses, doses, side effects or interactions of any medicine that carries it, and nothing here is medical advice. Ask a pharmacist or doctor about the medicine itself.

Where it sits in a name

WHO writes the stem as gli, without hyphens, which means it can sit anywhere in a name. So the letters gli sit anywhere in the name (gli).

All 112 names WHO lists under gli

These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.

Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 20 of 112 names appear in these lists: 18 in the US list (FDA Drugs@FDA) and 16 in the EU central list (EMA); 16 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.

  1. adomeglivant
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  2. aleglitazar
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  3. alogliptin
    US brands: NESINA
    in combination: KAZANO with metformin; OSENI with pioglitazone
    EU (central) brands: Vipidia
    in combination: Incresync with pioglitazone; Vipdomet with metformin
  4. anagliptin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  5. atigliflozin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  6. azemiglitazone
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  7. balaglitazone
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  8. bexagliflozin
    US brands: BRENZAVVY
    EU (central) brands: none found
  9. bisegliptin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  10. camiglibose
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  11. canagliflozin
    US brands: INVOKANA
    in combination: INVOKAMET with metformin; INVOKAMET XR with metformin
    EU (central) brands: Invokana
    in combination: Vokanamet with metformin
  12. carfloglitazar
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  13. carmegliptin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  14. cevoglitazar
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  15. ciglitazone
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  16. cofrogliptin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  17. dapagliflozin
    US brands: FARXIGA
    in combination: XIGDUO XR with metformin; QTERN (discontinued in FDA listings) with saxagliptin; QTERNMET XR (discontinued in FDA listings) with metformin + saxagliptin
    EU (central) brands: Dapagliflozin Viatris, Edistride, Forxiga
    in combination: Ebymect with metformin; Qtern with saxagliptin; Xigduo with metformin; Qtrilmet (withdrawn) with metformin + saxagliptin
  18. darglitazone
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  19. denagliptin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  20. deriglidole
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  21. dorzagliatin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  22. dutogliptin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  23. edaglitazone
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  24. emiglitate
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  25. empagliflozin
    US brands: JARDIANCE
    in combination: GLYXAMBI with linagliptin; SYNJARDY with metformin; SYNJARDY XR with metformin; TRIJARDY XR with linagliptin + metformin
    EU (central) brands: Jardiance
    in combination: Glyxambi with linagliptin; Synjardy with metformin
  26. enavoglifozin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  27. englitazone
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  28. ertugliflozin
    US brands: STEGLATRO
    in combination: SEGLUROMET with metformin; STEGLUJAN with sitagliptin
    EU (central) brands: Steglatro
    in combination: Segluromet with metformin; Steglujan with sitagliptin
  29. evogliptin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  30. farglitazar
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  31. fasiglifam
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  32. firuglipel
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  33. garvagliptin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  34. gemigliptin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  35. gliamilide
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  36. glibenclamide
    US brands: none found
    EU (central) brands: Amglidia
  37. glibornuride
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  38. glibutimine
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  39. glicaramide
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  40. glicetanile
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  41. gliclazide
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  42. glicondamide
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  43. glidazamide
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  44. gliflumide
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  45. glimepiride
    US brands: AMARYL (discontinued in FDA listings)
    in combination: DUETACT with pioglitazone; AVANDARYL (discontinued in FDA listings) with rosiglitazone
    EU (central) brands, in combination: Tandemact with pioglitazone; Avaglim (withdrawn) with rosiglitazone
  46. glipalamide
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  47. glipentide
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  48. glipizide
    US brands: GLUCOTROL XL, GLUCOTROL (discontinued in FDA listings)
    in combination: METAGLIP (discontinued in FDA listings) with metformin
    EU (central) brands: none found
  49. gliquidone
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  50. glisamuride
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  51. glisentide
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  52. glisindamide
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  53. glisolamide
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  54. glisoxepide
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  55. gosogliptin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  56. imeglimin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  57. imiglitazar
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  58. indeglitazar
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  59. ingliforib
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  60. ipragliflozin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  61. isaglidole
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  62. leriglitazone
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  63. licogliflozin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  64. limiglidole
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  65. linagliptin
    US brands: TRADJENTA
    in combination: GLYXAMBI with empagliflozin; JENTADUETO with metformin; JENTADUETO XR with metformin; TRIJARDY XR with empagliflozin + metformin
    EU (central) brands: Trajenta
    in combination: Glyxambi with empagliflozin; Jentadueto with metformin
  66. linogliride
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  67. lobeglitazone
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  68. luseogliflozin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  69. managlinat dialanetil
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  70. meglitinide
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  71. melogliptin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  72. midaglizole
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  73. miglitol
    US brands: GLYSET (discontinued in FDA listings)
    EU (central) brands: none found
  74. mitiglinide
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  75. mizagliflozin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  76. muroglitazar
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  77. naglivan
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  78. nateglinide
    US brands: STARLIX (discontinued in FDA listings)
    EU (central) brands: Starlix (withdrawn), Trazec (lapsed)
  79. naveglitazar
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  80. netoglitazone
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  81. omarigliptin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  82. oxeglitazar
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  83. peliglitazar
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  84. pemaglitazar
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  85. pioglitazone
    US brands: ACTOS
    in combination: ACTOPLUS MET with metformin; DUETACT with glimepiride; OSENI with alogliptin; ACTOPLUS MET XR (discontinued in FDA listings) with metformin
    EU (central) brands: Actos, Pioglitazone Accord, Pioglitazone Actavis, Glidipion (withdrawn), Glustin (withdrawn), Paglitaz (lapsed), Pioglitazone Krka (withdrawn), Pioglitazone Teva (withdrawn), Pioglitazone Teva Pharma (withdrawn), Sepioglin (withdrawn)
    in combination: Competact with metformin; Incresync with alogliptin; Tandemact with glimepiride; Glubrava (withdrawn) with metformin
  86. piragliatin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  87. pirogliride
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  88. prusogliptin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  89. ragaglitazar
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  90. reglitazar
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  91. remogliflozin etabonate
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  92. repaglinide
    US brands: PRANDIN (discontinued in FDA listings)
    in combination: PRANDIMET (discontinued in FDA listings) with metformin
  93. rivoglitazone
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  94. rosiglitazone
    US brands: AVANDIA (discontinued in FDA listings)
    in combination: AVANDAMET (discontinued in FDA listings) with metformin; AVANDARYL (discontinued in FDA listings) with glimepiride
    EU (central) brands: Avandia (expired), Nyracta (withdrawn), Venvia (withdrawn)
    in combination: Avaglim (withdrawn) with glimepiride; Avandamet (expired) with metformin
  95. saroglitazar
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  96. saxagliptin
    US brands: ONGLYZA (discontinued in FDA listings)
    in combination: KOMBIGLYZE XR (discontinued in FDA listings) with metformin; QTERN (discontinued in FDA listings) with dapagliflozin; QTERNMET XR (discontinued in FDA listings) with dapagliflozin + metformin
    EU (central) brands: Onglyza
    in combination: Komboglyze with metformin; Qtern with dapagliflozin; Qtrilmet (withdrawn) with dapagliflozin + metformin
  97. seglitide
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  98. sergliflozin etabonate
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  99. sipoglitazar
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  100. sitagliptin
    US brands: BRYNOVIN, JANUVIA, ZITUVIO
    in combination: JANUMET with metformin; JANUMET XR with metformin; STEGLUJAN with ertugliflozin; ZITUVIMET with metformin; ZITUVIMET XR with metformin; JUVISYNC (discontinued in FDA listings) with simvastatin
    in combination: Efficib with metformin; Janumet with metformin; Ristfor with metformin; Sitagliptin / Metformin hydrochloride Mylan with metformin; Sitagliptin / Metformin hydrochloride Sun with metformin; Steglujan with ertugliflozin; Velmetia with metformin; Sitagliptin / Metformin hydrochloride Accord (lapsed) with metformin
  101. sodelglitazar
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  102. sotagliflozin
    US brands: INPEFA
    EU (central) brands: Zynquista (withdrawn)
  103. teglicar
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  104. teneligliptin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  105. tesaglitazar
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  106. tibeglisene
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  107. tofogliflozin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  108. trelagliptin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  109. troglitazone
    US brands: PRELAY (discontinued in FDA listings), REZULIN (discontinued in FDA listings)
    EU (central) brands: none found
  110. velagliflozin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  111. vildagliptin
    US brands: none found
    EU (central) brands: Galvus, Jalra, Xiliarx
    in combination: Eucreas with metformin; Icandra with metformin; Vildagliptin / Metformin hydrochloride Accord with metformin; Zomarist with metformin
  112. voglibose
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)

US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.

EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.

EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.

Names with these letters that are not antihyperglycaemics

WHO lists these 6 names under gli, but says the stem is not used in its meaning here: group (b) of Part IV of the 2024 stem book, “INN in which the preferred stem has been used, but not in accordance with its definition”. The letters are marked where they sit; WHO’s note, where it gives one, is quoted as written. In these names, WHO’s definition of gli does not apply.

  1. cromoglicate lisetil
  2. cromoglicic acid
  3. ioglicic acid
  4. ioxaglic acid
  5. sulglicotide
  6. tropigline

Same group, without the stem

WHO also lists these 12 names under gli: group (c) of Part IV of the 2024 stem book, “INN which belong to the same group of pharmaceutical substances but in which the stem is not used”. They belong to the same group of substances as the group (a) names above, yet they do not carry gli, so the name alone does not reveal the group.

  1. acetohexamide
  2. butadiazamide
  3. carbutamide
  4. chlorpropamide
  5. heptolamide
  6. metahexamide
  7. palmoxiric acid
  8. thiohexamide
  9. tolazamide
  10. tolbutamide
  11. tolpentamide
  12. tolpyrramide

Decode another name

Decoded

miglitol

Listed INNCarries the WHO stem gli

  • gliinside the nameWHO lists it hereWHO definition: antihyperglycaemics

“miglitol” is an INN that WHO lists under gli in the 2024 stem book.

The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.

Source and licence

The definition of gli (Part II B) and the 112 names (Part IV, group (a)), and the 6 not in accordance with it (group (b)) and 12 of the same group without the stem (group (c)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .

Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.

Made with AI tools. · Privacy